While Oncology Institute Inc has underperformed by -8.40%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, TOI fell by -55.32%, with highs and lows ranging from $2.20 to $0.13, whereas the simple moving average jumped by 99.67% in the last 200 days.
On February 26, 2024, Jefferies started tracking Oncology Institute Inc (NASDAQ: TOI) recommending Buy. A report published by Guggenheim on September 14, 2022, Initiated its previous ‘Buy’ rating for TOI. Jefferies also rated TOI shares as ‘Buy’, setting a target price of $10 on the company’s shares in an initiating report dated August 15, 2022.
Analysis of Oncology Institute Inc (TOI)
Further, the quarter-over-quarter increase in sales is 21.78%, showing a positive trend in the upcoming months.
One of the most important indicators of Oncology Institute Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -131.66% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.27, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and TOI is recording 2.12M average volume. On a monthly basis, the volatility of the stock is set at 23.71%, whereas on a weekly basis, it is put at 19.78%, with a gain of 16.94% over the past seven days. Furthermore, long-term investors anticipate a median target price of $2.00, showing growth from the present price of $0.92, which can serve as yet another indication of whether TOI is worth investing in or should be passed over.
How Do You Analyze Oncology Institute Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 51.29%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 16.52% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
TOI shares are owned by institutional investors to the tune of 16.52% at present.
